SEOM clinical guidelines for the treatment of non-small cell lung cancer (NSCLC) 2015

被引:47
作者
Garcia-Campelo, R. [1 ]
Bernabe, R. [2 ]
Cobo, M. [3 ]
Corral, J. [4 ]
Coves, J. [5 ]
Domine, M. [6 ]
Nadal, E. [7 ]
Rodriguez-Abreu, D. [8 ]
Vinolas, N. [9 ]
Massuti, B. [10 ]
机构
[1] CHU A Coruna, Dept Med Oncol, Coruna, Spain
[2] Hosp Univ Nstra Sra de Valme, Dept Med Oncol, Seville, Spain
[3] Hosp Univ Malaga, Dept Med Oncol, Malaga, Spain
[4] Hosp Univ Virgen del Rocio, Dept Med Oncol, Seville, Spain
[5] Hosp Son Llatzer, Dept Med Oncol, Palma De Mallorca, Spain
[6] Hosp Univ Fdn Jimenez Diaz, Oncohlth Inst, Madrid, Spain
[7] Inst Catalan Oncol, Dept Med Oncol, Barcelona, Spain
[8] Hosp Univ Insular Las Palmas Gran Canaria, Dept Med Oncol, Las Palmas Gran Canaria, Spain
[9] Hosp Clin Barcelona, Dept Med Oncol, Barcelona, Spain
[10] Hosp Gen Univ Alicante, Dept Med Oncol, Alicante, Spain
关键词
NSCLC; Radiotherapy; Chemotherapy; Targeted therapies; PLATINUM-BASED CHEMOTHERAPY; PHASE-III TRIAL; 1ST-LINE TREATMENT; RANDOMIZED-TRIAL; ELDERLY-PATIENTS; DOCETAXEL; CISPLATIN; METAANALYSIS; CARBOPLATIN; RADIOTHERAPY;
D O I
10.1007/s12094-015-1455-z
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Lung cancer is the most common cancer worldwide as well as the leading cause of cancer related deaths as reported by Torre et al (CA Cancer J Clin 65: 87-108, 2015]. Non-small cell lung cancer (NSCLC) accounts for up to 85 % of all lung cancers. Multiple advances in the staging, diagnostic procedures, therapeutic options, as well as molecular knowledge have been achieved during the past years, although the overall outlook has not greatly changed for the majority of patients with the overall 5-year survival having marginally increased over the last decade from 15.7 to 17.4 % as reported by Howlader et al. (SEER Cancer Statistics Review 2015).
引用
收藏
页码:1020 / 1029
页数:10
相关论文
共 46 条
[1]   Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial [J].
Albain, Kathy S. ;
Swann, R. Suzanne ;
Rusch, Valerie W. ;
Turrisi, Andrew T., III ;
Shepherd, Frances A. ;
Smith, Colum ;
Chen, Yuhchyau ;
Livingston, Robert B. ;
Feins, Richard H. ;
Gandara, David R. ;
Fry, Willard A. ;
Darling, Gail ;
Johnson, David H. ;
Green, Mark R. ;
Miller, Robert C. ;
Ley, Joanne ;
Sause, Willliam T. ;
Cox, James D. .
LANCET, 2009, 374 (9687) :379-386
[2]  
[Anonymous], COCHRANE DATABASE SY
[3]  
[Anonymous], 2015, SEER cancer statistics review, 19752012
[4]   Cisplatin-versus carboplatin-based chemotherapy in first-line treatment of advanced non-small-cell lung cancer: An individual patient data meta-analysis [J].
Ardizzoni, Andrea ;
Boni, Luca ;
Tiseo, Marcello ;
Fossella, Frank V. ;
Schiller, Joan H. ;
Paesmans, Marianne ;
Radosavljevic, Davorin ;
Paccagnella, Adriano ;
Zatloukal, Petr ;
Mazzanti, Paola ;
Bisset, Donald ;
Rosell, Rafael .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (11) :847-857
[5]   An Individual Patient Data Metaanalysis of Outcomes and Prognostic Factors After Treatment of Oligometastatic Non-Small-Cell Lung Cancer [J].
Ashworth, Allison B. ;
Senan, Suresh ;
Palma, David A. ;
Riquet, Marc ;
Ahn, Yong Chan ;
Ricardi, Umberto ;
Congedo, Maria T. ;
Gomez, Daniel R. ;
Wright, Gavin M. ;
Melloni, Giulio ;
Milano, Michael T. ;
Sole, Claudio V. ;
De Pas, Tommaso M. ;
Carter, Dennis L. ;
Warner, Andrew J. ;
Rodrigues, George B. .
CLINICAL LUNG CANCER, 2014, 15 (05) :346-355
[6]   Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non-Small-Cell Lung Cancer [J].
Auperin, Anne ;
Le Pechoux, Cecile ;
Rolland, Estelle ;
Curran, Walter J. ;
Furuse, Kiyoyuki ;
Fournel, Pierre ;
Belderbos, Jose ;
Clamon, Gerald ;
Ulutin, Hakki Cuneyt ;
Paulus, Rebecca ;
Yamanaka, Takeharu ;
Bozonnat, Marie-Cecile ;
Uitterhoeve, Apollonia ;
Wang, Xiaofei ;
Stewart, Lesley ;
Arriagada, Rodrigo ;
Burdett, Sarah ;
Pignon, Jean-Pierre .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (13) :2181-2190
[7]   Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer [J].
Borghaei, H. ;
Paz-Ares, L. ;
Horn, L. ;
Spigel, D. R. ;
Steins, M. ;
Ready, N. E. ;
Chow, L. Q. ;
Vokes, E. E. ;
Felip, E. ;
Holgado, E. ;
Barlesi, F. ;
Kohlhaeufl, M. ;
Arrieta, O. ;
Burgio, M. A. ;
Fayette, J. ;
Lena, H. ;
Poddubskaya, E. ;
Gerber, D. E. ;
Gettinger, S. N. ;
Rudin, C. M. ;
Rizvi, N. ;
Crino, L. ;
Blumenschein, G. R. ;
Antonia, S. J. ;
Dorange, C. ;
Harbison, C. T. ;
Finckenstein, F. Graf ;
Brahmer, J. R. .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (17) :1627-1639
[8]   Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study [J].
Bradley, Jeffrey D. ;
Paulus, Rebecca ;
Komaki, Ritsuko ;
Masters, Gregory ;
Blumenschein, George ;
Schild, Steven ;
Bogart, Jeffrey ;
Hu, Chen ;
Forster, Kenneth ;
Magliocco, Anthony ;
Kavadi, Vivek ;
Garces, Yolanda I. ;
Narayan, Samir ;
Iyengar, Puneeth ;
Robinson, Cliff ;
Wynn, Raymond B. ;
Koprowski, Christopher ;
Meng, Joanne ;
Beitler, Jonathan ;
Gaur, Rakesh ;
Curran, Walter, Jr. ;
Choy, Hak .
LANCET ONCOLOGY, 2015, 16 (02) :187-199
[9]   Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer [J].
Brahmer, Julie ;
Reckamp, Karen L. ;
Baas, Paul ;
Crino, Lucio ;
Eberhardt, Wilfried E. E. ;
Poddubskaya, Elena ;
Antonia, Scott ;
Pluzanski, Adam ;
Vokes, Everett E. ;
Holgado, Esther ;
Waterhouse, David ;
Ready, Neal ;
Gainor, Justin ;
Aren Frontera, Osvaldo ;
Havel, Libor ;
Steins, Martin ;
Garassino, Marina C. ;
Aerts, Joachim G. ;
Domine, Manuel ;
Paz-Ares, Luis ;
Reck, Martin ;
Baudelet, Christine ;
Harbison, Christopher T. ;
Lestini, Brian ;
Spigel, David R. .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (02) :123-135
[10]   Postoperative radiotherapy in non-small-cell lung cancer: update of an individual patient data meta-analysis [J].
Burdett, S ;
Stewart, L .
LUNG CANCER, 2005, 47 (01) :81-83